Earnings Call · Q3 FY2021·2021-11-09

Q3 21EPS -22.22%·Rev n/aQ2 21EPS +36.84%·Rev n/aQ1 21EPS -11.11%·Rev n/aQ4 20EPS +13.64%·Rev n/a⚠ consensus missing

CorMedix Inc. CRMD

Dan Ferry — Investor Relations or Corporate Communications

Matt David — Interim Chief Executive Officer, Executive Vice President, and Chief Financial Officer

Phoebe Mounts — Executive Vice President and General Counsel

+1.5%1d on move date+2.3% vs SPY3d+0.8%5d−0.6%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more CRMD calls or request research access.

More CRMD calls Browse calls Request research access